Cargando…
Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial
BACKGROUND: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining quest...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gunther Eysenbach
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846344/ https://www.ncbi.nlm.nih.gov/pubmed/22262728 http://dx.doi.org/10.2196/jmir.1657 |
_version_ | 1782293417975349248 |
---|---|
author | van Bastelaar, Kim MP Pouwer, François Cuijpers, Pim Riper, Heleen Twisk, Jos WR Snoek, Frank J |
author_facet | van Bastelaar, Kim MP Pouwer, François Cuijpers, Pim Riper, Heleen Twisk, Jos WR Snoek, Frank J |
author_sort | van Bastelaar, Kim MP |
collection | PubMed |
description | BACKGROUND: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining question is whether the effectiveness differs between patients with seriously impaired mental health and patients with less severe mental health problems. OBJECTIVE: To test whether the effectiveness of an eight-lesson Web-based, diabetes-specific CBT for depression, with minimal therapist support, differs in patients with or without diagnosed major depressive disorder (MDD), diagnosed anxiety disorder, or elevated diabetes-specific emotional distress (DM-distress). METHODS: We used data of 255 patients with diabetes with elevated depression scores, who were recruited via an open access website for participation in a randomized controlled trial, conducted in 2008–2009, comparing a diabetes-specific, Web-based, therapist-supported CBT with a 12-week waiting-list control group. We performed secondary analyses on these data to study whether MDD or anxiety disorder (measured using a telephone-administered diagnostic interview) and elevated DM-distress (online self-reported) are effect modifiers in the treatment of depressive symptoms (online self-reported) with Web-based diabetes-specific CBT. RESULTS: MDD, anxiety disorder, and elevated DM-distress were not significant effect modifiers in the treatment of self-assessed depressive symptoms with Web-based diabetes-specific CBT. CONCLUSIONS: This Web-based diabetes-specific CBT depression treatment is suitable for use in patients with severe mental health problems and those with a less severe clinical profile. CLINICALTRIAL: International Standard Randomized Controlled Trial Number (ISRCTN): 24874457; http://www.controlled-trials.com/ISRCTN24874457 (Archived by WebCite at http://www.webcitation.org/63hwdviYr) |
format | Online Article Text |
id | pubmed-3846344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Gunther Eysenbach |
record_format | MEDLINE/PubMed |
spelling | pubmed-38463442013-12-03 Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial van Bastelaar, Kim MP Pouwer, François Cuijpers, Pim Riper, Heleen Twisk, Jos WR Snoek, Frank J J Med Internet Res Original Paper BACKGROUND: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining question is whether the effectiveness differs between patients with seriously impaired mental health and patients with less severe mental health problems. OBJECTIVE: To test whether the effectiveness of an eight-lesson Web-based, diabetes-specific CBT for depression, with minimal therapist support, differs in patients with or without diagnosed major depressive disorder (MDD), diagnosed anxiety disorder, or elevated diabetes-specific emotional distress (DM-distress). METHODS: We used data of 255 patients with diabetes with elevated depression scores, who were recruited via an open access website for participation in a randomized controlled trial, conducted in 2008–2009, comparing a diabetes-specific, Web-based, therapist-supported CBT with a 12-week waiting-list control group. We performed secondary analyses on these data to study whether MDD or anxiety disorder (measured using a telephone-administered diagnostic interview) and elevated DM-distress (online self-reported) are effect modifiers in the treatment of depressive symptoms (online self-reported) with Web-based diabetes-specific CBT. RESULTS: MDD, anxiety disorder, and elevated DM-distress were not significant effect modifiers in the treatment of self-assessed depressive symptoms with Web-based diabetes-specific CBT. CONCLUSIONS: This Web-based diabetes-specific CBT depression treatment is suitable for use in patients with severe mental health problems and those with a less severe clinical profile. CLINICALTRIAL: International Standard Randomized Controlled Trial Number (ISRCTN): 24874457; http://www.controlled-trials.com/ISRCTN24874457 (Archived by WebCite at http://www.webcitation.org/63hwdviYr) Gunther Eysenbach 2012-01-05 /pmc/articles/PMC3846344/ /pubmed/22262728 http://dx.doi.org/10.2196/jmir.1657 Text en ©Kim MP van Bastelaar, François Pouwer, Pim Cuijpers, Heleen Riper, Jos WR Twisk, Frank J Snoek. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 05.01.2012. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper van Bastelaar, Kim MP Pouwer, François Cuijpers, Pim Riper, Heleen Twisk, Jos WR Snoek, Frank J Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial |
title | Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial |
title_full | Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial |
title_fullStr | Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial |
title_full_unstemmed | Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial |
title_short | Is a Severe Clinical Profile an Effect Modifier in a Web-Based Depression Treatment for Adults With Type 1 or Type 2 Diabetes? Secondary Analyses From a Randomized Controlled Trial |
title_sort | is a severe clinical profile an effect modifier in a web-based depression treatment for adults with type 1 or type 2 diabetes? secondary analyses from a randomized controlled trial |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846344/ https://www.ncbi.nlm.nih.gov/pubmed/22262728 http://dx.doi.org/10.2196/jmir.1657 |
work_keys_str_mv | AT vanbastelaarkimmp isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial AT pouwerfrancois isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial AT cuijperspim isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial AT riperheleen isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial AT twiskjoswr isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial AT snoekfrankj isasevereclinicalprofileaneffectmodifierinawebbaseddepressiontreatmentforadultswithtype1ortype2diabetessecondaryanalysesfromarandomizedcontrolledtrial |